The new digital platform reinforces CELLnTEC’s positioning as the pioneer in chemically defined, animal-free tissue culture and a leader in epithelial and skin tissue engineering.
BERN, Switzerland [20th July 2026] — CELLnTEC Advanced Cell Systems AG, a Swiss life science company specializing in precision cell culture technologies, today announced the launch of its new website at www.cellntec.com.
The new website reflects CELLnTEC’s leadership position
in chemically defined, animal-free tissue culture, with a focus on
enabling robust, reproducible, and scalable workflows for 2D & 3D cell
culture, tissue engineering, stem cell research, advanced in vitro test
model and New Approach Methodologies (NAMs), and ATMP-development.
For more than two decades, CELLnTEC has developed
specialty media and cell culture systems designed to support high-performance cell
and tissue culture. The new digital platform makes it easier for users to
explore CELLnTEC’s solutions by product type, cell type, and application area,
helping researchers identify appropriate tools for epithelial proliferation,
differentiation, co-culture, 3D models, or barrier-forming tissues, and
translational workflows.
“Our new website is more than a refreshed digital
presence. It is a practical resource for the scientific and industrial
communities we serve,” said Anand David, Head of Scientific Marketing at
CELLnTEC. “By improving access to product information, protocols, application
knowledge, and distributor resources, we are making it easier for researchers
and developers to select chemically defined, animal-free culture systems that
support reproducibility, biological relevance, and future clinical or
industrial translation.”
The new website highlights CELLnTEC’s role across
several fast-growing areas of life science innovation:
The Pioneer in Chemically Defined, Animal-Free Tissue
Culture
Leader in Epithelial Tissue Engineering
Supplier to Stem Cell Research
Enabler of Advanced In Vitro Test Models and NAMs
Development
Supplier to ATMP Developers and Translational Research
Teams
Key features and highlights of the redesigned CELLnTEC website
include:
Enhanced Digital Experience A more intuitive experience across desktop, tablet, and
mobile devices, helping scientists, industry partners, distributors, and
translational research teams access product information, technical support, and
other key resources more efficiently. Streamlined sample and quotation
requests, along with quick access to distributor details for international
customers.
Advanced Product Discovery Faster navigation through CELLnTEC’s portfolio of
chemically defined, xeno-free, and serum-free cell culture technologies, along
with refined search functionality, and clearer product specification
comparisons. These improvements support both experienced CELLnTEC users and new
customers evaluating animal-free, defined culture systems for research and
development.
Application-Specific Solutions Expanded application pages help users identify solutions
across skin, respiratory, MSC, and other research areas, with seamless access
to relevant product selection and workflow-specific resources.
Enhanced Knowledge Hub A centralized knowledge hub provides quick access to
research-relevant information, including scientific literature, protocols,
product catalogs, technical documents, and FAQs to support advanced in vitro 3D
modeling.
Supporting Translational Workflows Improved access to technical information to identify CELLnTEC’s
Higher Certified solutions designed to support translational workflows.
The new CELLnTEC website is now live at www.cellntec.com.
About CELLnTEC Advanced Cell Systems AG
Media Contact:
CELLnTEC’s media technologies are designed to reduce variability and support
reproducible cell culture by using chemically defined formulations free from
animal-derived components.
CELLnTEC supports the development of physiologically relevant epithelial
models, including 2D and 3D systems used in barrier biology, toxicology,
disease modeling, drug candidate screening, tissue engineering, and across organ
modalities from skin/dermatology, eye/ophthalmology, airway/pulmonology to
liver/hepatology.
CELLnTEC products support workflows involving primary epithelial cells, adult
stem cell populations, iPSC-derived cells, and established cell lines, helping
researchers maintain controlled and standardized culture conditions.
As the life science industry continues to adopt more predictive, human-relevant
in vitro systems, CELLnTEC provides cell culture solutions that help
researchers develop advanced test models aligned with New Approach
Methodologies.
CELLnTEC’s clinically upgradable and defined cell culture technologies support
developers working toward cell-based therapies, regenerative medicine, and
ATMP-related workflows.
CELLnTEC Advanced Cell
Systems AG is a Swiss life science company developing precision cell culture
technologies for epithelial biology, tissue engineering, stem cell research,
advanced in vitro models, and translational applications. The company is
recognized for its chemically defined, animal-component-free media and
specialty culture systems that support reproducible 2D and 3D workflows across
research and industry.
Anand David, PhD
Head of Scientific Marketing
CELLnTEC Advanced Cell Systems AG
marketing@cellntec.com
+41313319582
www.cellntec.com
